-

Three Hundred Fifty Life Science Executives Participated in Trinity’s Bi-annual Think Tank, the TGaS Fall Summit

Advisory Brief Summarizing Key Take-aways from Summit Now Available

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in global life sciences solutions, found that the key themes from last month’s virtual TGaS Fall Summit included COVID’s impact on engagement and the life sciences commercial model as well as how to lead the commercial model transformation in 2021.

The 350 attendees from 111 life sciences companies joined the Summit and participated in conversations about:

  • Team engagement and motivation
  • The new commercial model, including modifications in client-facing roles and the evolution of digital and virtual capabilities
  • Expanded opportunities to leverage artificial intelligence and machine learning

“It is not surprising that we focused the Fall Summit on transforming the commercial model in the COVID era,” said Gary McWalters, President of TGaS Advisors, a Division of Trinity. “Attendees of our Summit, which is essentially a life sciences-based executive think tank, shared perspectives, made recommendations, and collectively thought through alternative paths forward relative to critical COVID-related topics.”

An advisory brief entitled Transforming the Commercial Model in the Age of COVID-19 summarizing the key takeaways from the Summit is now available. Media interested in requesting a copy of the brief should contact Elizabeth Marshall at emarshall@trinitylifesciences.com.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Summary
Three hundred fifty life science executives participated in Trinity's bi-annual think tank, the TGaS Fall Summit.
Release Versions

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom